{"id":"W4391095740","doi":"10.1200/jco.2024.42.3_suppl.129","title":"A first-in-human, open-label, phase I trial of daily oral zelenirstat, an NMT inhibitor, in patients with relapsed/refractory advanced cancer including gastrointestinal cancers.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Nausea; Tolerability; Internal medicine; Adverse effect; Gastroenterology; Cancer; Vomiting; Refractory (planetary science); Colorectal cancer; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008779386,0.001471567,0.001574429,0.0003678744,0.0004547212,0.0007936913,0.0008944977,0.00112375,0.00368586],"category_scores_gemma":[0.0005033394,0.000642585,0.0009793176,0.0002934358,0.0009105027,0.0008654353,0.0003268493,0.002653884,0.001076985],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009230083,"about_ca_system_score_gemma":0.001315824,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009008792,"about_ca_topic_score_gemma":0.002916884,"domain_scores_codex":[0.9997873,0.00007636381,0.00001003107,0.000045679,0.0000176484,0.00006299032],"domain_scores_gemma":[0.9995739,0.0000647405,0.00006884785,0.00003914409,0.00002605135,0.000227242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6999344,0.09309515,0.007380143,0.0009720697,0.00117743,0.0005840245,0.000424074,0.003600466,0.08853717,0.0003750425,0.007766604,0.09615333],"study_design_scores_gemma":[0.4484053,0.5254949,0.01199728,0.0000282245,0.0003426604,0.0005539272,0.00007450574,0.001873368,0.006610624,0.0002520809,0.004332958,0.00003421841],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914232,0.001250172,0.0006125025,0.0003197906,0.00009892356,0.002589712,0.001428739,0.0001519171,0.00212514],"genre_scores_gemma":[0.9888406,0.001058216,0.001465785,0.0006329408,0.0001073001,0.002183575,0.002687752,0.0000385181,0.002985303],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00368586,"threshold_uncertainty_score":0.01233041,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1394459851429618,"score_gpt":0.5023822377590372,"score_spread":0.3629362526160754,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}